edaravone

Ukraine

Drugs containing this active substance

  • FLEERTIS

    The drug is used to alleviate neurological symptoms and functional impairments following an acute ischemic stroke, as well as to slow the progression of functional disorders in amyotrophic lateral sclerosis (ALS).

    Form: solution for injection

    Active substance Dosage
    edaravone 1.5 mg/ml

    ATC: N07XX14

    Manufacturer: Farmak JSC

  • The drug is used for the treatment of amyotrophic lateral sclerosis (ALS).

    Form: solution for infusion

    Active substance Dosage
    edaravone 0.3 mg/ml

    ATC: N07XX14

    Manufacturer: Farmak JSC

  • The drug is used to alleviate neurological symptoms and functional disorders in acute ischemic stroke, to slow the progression of amyotrophic lateral sclerosis (ALS), and as part of complex treatment for the systemic inflammatory response in coronavirus disease (COVID-19).

    Form: solution for injection

    Active substance Dosage
    edaravone 1.5 mg/ml

    ATC: N07XX14

    Manufacturer: Yuria-Pharm LLC